AGENA AND DARUI BIOTECHNOLOGY ANNOUNCE CHINA FDA CLEARANCE OF MASSARRAY TECHNOLOGY FOR DIAGNOSTIC USE IN CHINA

SAN DIEGO, Calif., and GUANGZHOU, China, Wednesday, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnology (DaRui) announced today that the MassARRAY System has formally passed the registration application of Guangdong Food and Drug Administration, becoming the first CFDA approved MALDI-TOF mass spectrometry system to directly detect nucleic acids for in vitro diagnostics in … Continue reading AGENA AND DARUI BIOTECHNOLOGY ANNOUNCE CHINA FDA CLEARANCE OF MASSARRAY TECHNOLOGY FOR DIAGNOSTIC USE IN CHINA